{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:18:28Z","timestamp":1787800708697,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aims<\/jats:title>\n            <jats:p>Non-alcoholic steatohepatitis (NASH) is a\u00a0severe form of non-alcoholic fatty liver disease (NAFLD), characterized by hepatic inflammation and damage due to fat accumulation. Psoriasis patients show higher NASH incidence due to overlapping risk factors like obesity and insulin resistance. The study aimed to determine the incidence of non-alcoholic steatohepatitis in patients with psoriasis vulgaris.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This cross-sectional observational study included 80\u00a0adult patients diagnosed with psoriasis vulgaris. Psoriasis severity was assessed using the Psoriasis Area and Severity Index (PASI) score. All participants underwent abdominal ultrasonography to assess liver steatosis. Those with significant findings suggestive of fatty liver were further evaluated with transient elastography (FibroScan, EchoSens, Paris, France) to determine liver stiffness and controlled attenuation parameter (CAP) values.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among psoriatic patient diagnosed with NASH, the mean PASI score was 8.8\u202f\u00b1\u20093.6 which was higher than those diagnosed with NAFLD and non-NASH non-NAFLD patients (6.7\u202f\u00b1\u20094.5 and 7.1\u202f\u00b1\u20093.9, respectively); however, this difference was not statistically significant (<jats:italic>P<\/jats:italic>\u202f=\u20090.19). The percentage of moderate and severe psoriasis was higher in NASH patients (68.75%) compared to NAFLD and non-NASH non-NAFLD subjects (57.1% and 46.5%, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>NASH and NAFLD are linked to psoriasis severity and systemic metabolic dysfunction. Future studies with larger cohorts and prospective designs are needed to validate these findings and explore underlying mechanisms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphic abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s10354-025-01107-6","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T07:28:47Z","timestamp":1756452527000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-alcoholic steatohepatitis incidence in patients with psoriasis vulgaris"],"prefix":"10.1007","volume":"175","author":[{"given":"Hanaa Mohamed","family":"Elhanon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabie B.","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan M.","family":"Eldahshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad El Deen","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-5241","authenticated-orcid":false,"given":"Mohamed L.","family":"Elsaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"6","key":"1107_CR1","first-page":"e13988","volume":"33","author":"HA Nada","year":"2020","unstructured":"Nada\u00a0HA, Elshabrawy\u00a0MM, Ismail\u00a0NI, Hassan\u00a0ET, Jafferany\u00a0M, Elsaie\u00a0ML. Therapeutic implications and role of serum sphingolipids on psoriasis severity after narrow band ultraviolet B treatment: a\u00a0cross-sectional controlled study. Dermatol Ther. 2020;33(6):e13988.","journal-title":"Dermatol Ther"},{"issue":"6","key":"1107_CR2","first-page":"33","volume":"11","author":"O Awosika","year":"2018","unstructured":"Awosika\u00a0O, Eleryan\u00a0MG, Rengifo-Pardo\u00a0M, Doherty\u00a0L, Martin\u00a0LW, Ehrlich\u00a0A. A\u00a0case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis. J\u00a0Clin Aesthet Dermatol. 2018;11(6):33\u20137.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"13","key":"1107_CR3","doi-asserted-by":"publisher","first-page":"840106","DOI":"10.3389\/fimmu.2022.840106","volume":"16","author":"SY Gau","year":"2022","unstructured":"Gau\u00a0SY, Huang\u00a0KH, Lee\u00a0CH, Kuan\u00a0YH, Tsai\u00a0TH, Lee\u00a0CY. Bidirectional association between psoriasis and nonalcoholic fatty liver disease: real-world evidence from two longitudinal cohort studies. Front Immunol. 2022;16(13):840106.","journal-title":"Front Immunol"},{"issue":"1","key":"1107_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cld.2007.02.014","volume":"11","author":"P Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya\u00a0P, Lindor\u00a0KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007;11(1):37\u201354.","journal-title":"Clin Liver Dis"},{"issue":"9","key":"1107_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamadermatol.2019.0721","volume":"155","author":"CM Maybury","year":"2019","unstructured":"Maybury\u00a0CM, Porter\u00a0HF, Kloczko\u00a0E, Duckworth\u00a0M, Cotton\u00a0A, Thornberry\u00a0K, Dew\u00a0T, Crook\u00a0M, Natas\u00a0S, Miquel\u00a0R, Lewis\u00a0CM, Wong\u00a0T, Smith\u00a0CH, Barker\u00a0JN. Prevalence of advanced liver fibrosis in patients with severe psoriasis. JAMA Dermatol. 2019;155(9):1028\u201332.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1107_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1159\/000520163","volume":"238","author":"JHO Hoffmann","year":"2022","unstructured":"Hoffmann\u00a0JHO, Enk\u00a0AH. Evaluation of psoriasis area and severity index thresholds as proxies for systemic inflammation on an individual patient level. Dermatology. 2022;238(4):609\u201314.","journal-title":"Dermatology"},{"issue":"7","key":"1107_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam\u00a0M, Sanyal\u00a0AJ, George\u00a0J, International Consensus Panel. MAFLD: a\u00a0consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u20132014.e1.","journal-title":"Gastroenterology"},{"issue":"11","key":"1107_CR8","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3390\/jcm9113594","volume":"9","author":"P Gisondi","year":"2020","unstructured":"Gisondi\u00a0P, Bellinato\u00a0F, Girolomoni\u00a0G. Topographic differential diagnosis of chronic plaque psoriasis: challenges and tricks. J\u00a0Clin Med. 2020;9(11):3594.","journal-title":"J Clin Med"},{"issue":"3","key":"1107_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1440-0960.2012.00905.x","volume":"53","author":"S Madanagobalane","year":"2012","unstructured":"Madanagobalane\u00a0S, Anandan\u00a0S. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a\u00a0study from south India. Australas J Dermatol. 2012;53(3):190\u20137.","journal-title":"Australas J Dermatol"},{"issue":"3","key":"1107_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/apt.13042","volume":"41","author":"KK Roberts","year":"2015","unstructured":"Roberts\u00a0KK, Cochet\u00a0AE, Lamb\u00a0PB, Brown\u00a0PJ, Battafarano\u00a0DF, Brunt\u00a0EM, Harrison\u00a0SA. The prevalence of NAFLD and NASH among patients with psoriasis in a\u00a0tertiary care dermatology and rheumatology clinic. Aliment Pharmacol Ther. 2015;41(3):293\u2013300.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1107_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ijms17020217","volume":"17","author":"A Mantovani","year":"2016","unstructured":"Mantovani\u00a0A, Gisondi\u00a0P, Lonardo\u00a0A, Targher\u00a0G. Relationship between non-alcoholic fatty liver disease and psoriasis: a\u00a0novel hepato-dermal axis? Int J Mol Sci. 2016;17(2):217.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1107_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets\u00a0CA, Leonardi\u00a0CL, Davis\u00a0DMR, Gelfand\u00a0JM, Lichten\u00a0J, Mehta\u00a0NN, Armstrong\u00a0AW, Connor\u00a0C, Cordoro\u00a0KM, Elewski\u00a0BE, Gordon\u00a0KB, Gottlieb\u00a0AB, Kaplan\u00a0DH, Kavanaugh\u00a0A, Kivelevitch\u00a0D, Kiselica\u00a0M, Korman\u00a0NJ, Kroshinsky\u00a0D, Lebwohl\u00a0M, Lim\u00a0HW, Paller\u00a0AS, Parra\u00a0SL, Pathy\u00a0AL, Prater\u00a0EF, Rupani\u00a0R, Siegel\u00a0M, Stoff\u00a0B, Strober\u00a0BE, Wong\u00a0EB, Wu\u00a0JJ, Hariharan\u00a0V, Menter\u00a0A. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J\u00a0Am Acad Dermatol. 2019;80(4):1073\u2013113.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1107_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4254\/wjh.v7.i3.315","volume":"7","author":"G Ganzetti","year":"2015","unstructured":"Ganzetti\u00a0G, Campanati\u00a0A, Offidani\u00a0A. Non-alcoholic fatty liver disease and psoriasis: so far, so near. World J Hepatol. 2015;7(3):315\u201326.","journal-title":"World J Hepatol"},{"issue":"1","key":"1107_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bjd.16239","volume":"179","author":"RB Prussick","year":"2018","unstructured":"Prussick\u00a0RB, Miele\u00a0L. Nonalcoholic fatty liver disease in patients with psoriasis: a\u00a0consequence of systemic inflammatory burden? Br J Dermatol. 2018;179(1):16\u201329.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1107_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/09546634.2013.860209","volume":"26","author":"L Puig","year":"2015","unstructured":"Puig\u00a0L, Strohal\u00a0R, Husni\u00a0ME, Tsai\u00a0TF, Noppakun\u00a0N, Szumski\u00a0A, Yang\u00a0S, Robertson\u00a0D, Boggs\u00a0R, Koenig\u00a0AS. Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis. J\u00a0Dermatolog Treat. 2015;26(1):7\u201315.","journal-title":"J Dermatolog Treat"},{"issue":"9","key":"1107_CR16","doi-asserted-by":"publisher","first-page":"1068157","DOI":"10.3389\/fmed.2022.1068157","volume":"15","author":"T Yongpisarn","year":"2022","unstructured":"Yongpisarn\u00a0T, Namasondhi\u00a0A, Iamsumang\u00a0W, Rattanakaemakorn\u00a0P, Suchonwanit\u00a0P. Liver fibrosis prevalence and risk factors in patients with psoriasis: a\u00a0systematic review and meta-analysis. Front Med. 2022;15(9):1068157.","journal-title":"Front Med"},{"issue":"2","key":"1107_CR17","first-page":"e25","volume":"12","author":"DG Aly","year":"2013","unstructured":"Aly\u00a0DG, Abdallah\u00a0IY, Hanafy\u00a0NS, Elsaie\u00a0ML, Hafiz\u00a0NA. Elevated serum leptin levels in nonobese patients with psoriasis. J\u00a0Drugs Dermatol. 2013;12(2):e25\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"1107_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","volume":"158","author":"Z Ruan","year":"2022","unstructured":"Ruan\u00a0Z, Lu\u00a0T, Chen\u00a0Y, Yuan\u00a0M, Yu\u00a0H, Liu\u00a0R, Xie\u00a0X. Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults. JAMA Dermatol. 2022;158(7):745\u201353.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1107_CR19","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1038\/s41598-021-88043-8","volume":"11","author":"I Belinch\u00f3n-Romero","year":"2021","unstructured":"Belinch\u00f3n-Romero\u00a0I, Bellot\u00a0P, Romero-P\u00e9rez\u00a0D, Herraiz-Romero\u00a0I, Marco\u00a0F, Frances\u00a0R, Ramos-Rinc\u00f3n\u00a0JM. Non-alcoholic fatty liver disease is associated with bacterial translocation and a\u00a0higher inflammation response in psoriatic patients. Sci Rep. 2021;11(1):8593.","journal-title":"Sci Rep"},{"issue":"1","key":"1107_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","volume":"14","author":"Y Lin","year":"2022","unstructured":"Lin\u00a0Y, Feng\u00a0X, Cao\u00a0X, Miao\u00a0R, Sun\u00a0Y, Li\u00a0R, Ye\u00a0J, Zhong\u00a0B. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetol Metab Syndr. 2022;14(1):181.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"1107_CR21","doi-asserted-by":"publisher","first-page":"1400741","DOI":"10.3389\/fmed.2024.1400741","volume":"15","author":"Z Lin","year":"2024","unstructured":"Lin\u00a0Z, Shi\u00a0YY, Yu\u00a0LY, Ma\u00a0CX, Pan\u00a0SY, Dou\u00a0Y, Zhou\u00a0QJ, Cao\u00a0Y. Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a\u00a0case-control study and serological comparison. Front Med. 2024;15(11):1400741.","journal-title":"Front Med"},{"issue":"4","key":"1107_CR22","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","volume":"51","author":"L Miele","year":"2009","unstructured":"Miele\u00a0L, Vallone\u00a0S, Cefalo\u00a0C, La Torre\u00a0G, Di Stasi\u00a0C, Vecchio\u00a0FM, D\u2019Agostino\u00a0M, Gabrieli\u00a0ML, Vero\u00a0V, Biolato\u00a0M, Pompili\u00a0M, Gasbarrini\u00a0G, Rapaccini\u00a0G, Amerio\u00a0P, De Simone\u00a0C, Grieco\u00a0A. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J\u00a0Hepatol. 2009;51(4):778\u201386.","journal-title":"J Hepatol"},{"key":"1107_CR23","first-page":"897A","volume":"56","author":"A Fewell","year":"2012","unstructured":"Fewell\u00a0A, Lamb\u00a0PB, Roberts\u00a0KK, Katharine\u00a0K, Buttafarano\u00a0D, Owens\u00a0N, Harrison\u00a0A. The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) among patients with psoriasis and psoriatic arthritis in a\u00a0tertiary care dermatology and rheumatology clinic. Hepatology. 2012;56:897A.","journal-title":"Hepatology"},{"issue":"4","key":"1107_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.5114\/ada.2019.83983","volume":"37","author":"EH Klujszo","year":"2020","unstructured":"Klujszo\u00a0EH, Parcheta\u00a0P, Witkowska\u00a0AB, Krecisz\u00a0B. Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. Postepy Dermatol Alergol. 2020;37(4):468\u201374.","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-025-01107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-025-01107-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-025-01107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:24:38Z","timestamp":1760016278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-025-01107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":24,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1007\/s10354-025-01107-6","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.M.\u00a0Elhanon, R.B.\u00a0Atallah, R.M.\u00a0Eldahshan, S.E.D.\u00a0Mohamed and M.L.\u00a0Elsaie declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of the Faculty of Medicine (DFM-IRB 00012367-23-11-005) Al-Azhar University, Damietta; Egypt. Written informed consents were received from participants or their guardians upon explanation of the study. Participants were fully informed about the study objectives and procedures, and they retained the right to withdraw at any point without any consequences on their care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}